BRUNOLD C. ET AL.: 'Imetelstat, A Potent Telomerase Inhibitor, Inhibits the Spontaneous Growth of CFU-Meg In Vitro From Essential Thrombocythemia Patients but Not From Healthy Individuals' BLOOD (ASH ANNUAL MEETING ABSTRACTS vol. 118, no. 21, 18 November 2011, XP055254840 (B1)

BRASSAT U. ET AL.: 'Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells' EXPERIMENTAL HEMATOLOGY vol. 39, no. 1, January 2011, pages 66 - 76, XP027562087 (B1)

CLAUDIO BRUNOLD ET AL: "3843: Imetelstat, A Potent Telomerase Inhibitor, Inhibits the Spontaneous Growth of CFU-Meg In Vitro From Essential Thrombocythemia Patients but Not From Healthy Individuals", BLOOD, vol. 118, no. 21, 18 November 2011 (2011-11-18), - 13 December 2011 (2011-12-13), page 3843, XP55254840, US ISSN: 0006-4971 (B1)

CN-A- 101 220 044 (B1)

EL-DALY H. ET AL.: 'Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532' BLOOD vol. 105, no. 4, 15 February 2005, pages 1742 - 1749, XP055254432 (B1)

KAKIUCHI YASUTAKA ET AL: "Inhibition of Human Tumor Cell Proliferation by the Telomerase Inhibitor TELIN", CYTOLOGIA (TOKYO), vol. 75, no. 2, June 2010 (2010-06), pages 177-183, XP8180568, ISSN: 0011-4545 (B1)

KELLER G. ET AL.: 'Telomeres and telomerase in chronic myeloid leukemia: impact for pathogenesis, disease progression and targeted therapy' HEMATOLOGICAL ONCOLOGY vol. 27, no. 3, 2009, pages 123 - 129, XP055254435 (B1)

MARITZ M.F. ET AL.: 'Targeting telomerase in hematologic malignancy' FUTURE ONCOLOGY vol. 6, no. 5, 2010, pages 769 - 789, XP008178589 (B1)

ROTH A. ET AL.: 'Imetelstat (GRN163L)--telomerase-based cancer therapy' RECENT RESULTS IN CANCER RESEARCH vol. 184, 2010, pages 221 - 234, XP008179309 (B1)

ROTH A. ET AL.: 'Telomerase is limiting the growth of acute myeloid leukemia cells' LEUKEMIA vol. 17, no. 12, December 2003, pages 2410 - 2417, XP055254440 (B1)

SUMI M. ET AL.: 'A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia' INTERNATIONAL JOURNAL OF ONCOLOGY vol. 24, no. 6, 2004, pages 1481 - 1487, XP055254437 (B1)

TAUCHI TETSUZO ET AL: "Activity of a novel G-quadruplex-interactive telomerase inhibitor, SOT-095, against human leukemia cells: Involvement of ATM-dependent DNA damage response pathways", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, [Online] vol. 102, no. 11, 16 November 2003 (2003-11-16), page 652a, XP008180575, ISSN: 0006-4971 Retrieved from the Internet: URL:http://www.bloodjournal.org/> (B1)

US-A1- 2005 282 893 (B1)

WO-A2-2006/113426 (B1)

BAERLOCHER G.M. ET AL.: 'Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results' BLOOD (ASH ANNUAL MEETING ABSTRACTS vol. 120, no. 21, 16 November 2012, XP055254428 (B1)

BAERLOCHER GABRIELA M ET AL: "Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, [Online] vol. 120, no. 21, 1 November 2012 (2012-11-01), page 179, XP008180577, ISSN: 0006-4971 Retrieved from the Internet: URL:http://www.bloodjournal.org/> (B1)

CATENACCI ET AL: "Myelodysplasic syndromes: A comprehensive review", BLOOD REVIEWS, CHURCHILL LIVINGSTONE, AMSTERDAM, NL, vol. 19, no. 6, 1 November 2005 (2005-11-01), pages 301-319, XP005167052, ISSN: 0268-960X, DOI: 10.1016/J.BLRE.2005.01.004 (B1)